Investors

News Releases

Date Title  
Toggle Summary POZEN to Present at the Ladenburg Thalmann Healthcare Conference
CHAPEL HILL, N.C. --(BUSINESS WIRE)--Sep. 15, 2015-- POZEN Inc. (NASDAQ: POZN), a specialty pharmaceutical company, today announced that certain members of the executive management team will participate in the Ladenburg Thalmann Healthcare Conference to be held September 29, 2015 in New York .
Toggle Summary Tribute Comments on Trading Activity at the Request of IIROC
MILTON, ONTARIO -- (Marketwired) -- 09/29/15 -- Tribute Pharmaceuticals Canada Inc. (TSX VENTURE:TRX)(OTCQX:TBUFF) ("Tribute" or the "Company"), a specialty pharmaceutical company with a primary focus on the acquisition, licensing, development and promotion of healthcare products in Canada and the
Toggle Summary POZEN Inc. to Announce Third Quarter 2015 Results on November 9, 2015
Company to host call at 11:00 a.m. ET CHAPEL HILL, N.C. --(BUSINESS WIRE)--Oct. 26, 2015-- POZEN Inc. (NASDAQ: POZN) today announced that the Company plans to release results for the third quarter 2015 on Monday, November 9, 2015 , before the opening of the U.S. markets.
Toggle Summary POZEN and Tribute Announce Effectiveness of Registration Statement on Form S-4
    POZEN Schedules Stockholder Meeting for December 10, 2015     Tribute Schedules Shareholder Meeting for December 9, 2015     CHAPEL HILL, N.C. & MILTON, Ontario--November 6, 2015--POZEN Inc. ("POZEN")    (POZN) and Tribute Pharmaceuticals Canada Inc.
Toggle Summary POZEN Reports Third Quarter 2015 Results
Strategic Merger with Tribute Pharmaceuticals Still on Track to Close in December 2015 Commercial Launch Preparation Efforts for YOSPRALA TM Well Underway CHAPEL HILL, N.C. --(BUSINESS WIRE)--Nov. 9, 2015-- POZEN Inc. (NASDAQ: POZN) , today announced results for the third quarter ended September
Toggle Summary Tribute Announces Third Quarter 2015 Results
    Revenue Up 133%, EBITDA Up 281% Over    Comparative Period     MILTON, ONTARIO -- (Marketwired) -- 11/09/15 -- Tribute Pharmaceuticals Canada    Inc. (TSX VENTURE:TRX)(OTCQX:TBUFF) ("Tribute" or the "Company"), a diversified    healthcare company with a primary focus on the acquisition,
Toggle Summary POZEN And Tribute Provide Update On Pending Combination Transactions
-POZEN and Tribute Evaluating Canadian Domicile for Aralez Pharmaceuticals- CHAPEL HILL, NORTH CAROLINA and MILTON, ONTARIO -- ( Marketwired ) -- 11/23/15 -- POZEN Inc. ("POZEN") (NASDAQ:POZN) and Tribute Pharmaceuticals Canada Inc. ("Tribute") (TSX VENTURE:TRX) (OTCQX:TBUFF) today provided an
Toggle Summary POZEN and Tribute Announce Plan to Proceed With Merger to Form Aralez Pharmaceuticals
     -Canada Domicile Provides Similar Competitive    Structure and Benefits to Ireland-     -Previously Scheduled Shareholder Meetings of    POZEN and Tribute to be Rescheduled-     CHAPEL HILL, NORTH CAROLINA and MILTON, ONTARIO -- (Marketwired) -- 12/07/15 --    POZEN Inc.
Toggle Summary POZEN And Tribute Announce Plan To Proceed With Merger To Form Aralez Pharmaceuticals
- US$350 Million Capital Commitment from Deerfield-Led Syndicate- -Canada Domicile Provides Similar Competitive Structure and Benefits to Ireland - -Previously Scheduled Shareholder Meetings of POZEN and Tribute to be Rescheduled- CHAPEL HILL, N.C. and MILTON, Ontario , Dec.
Toggle Summary Tribute Schedules Special Shareholder Meeting for February 1, 2016
    MILTON, ONTARIO -- (Marketwired) -- 12/28/15 -- Tribute Pharmaceuticals Canada    Inc. (TSX VENTURE:TRX) (OTCQX:TBUFF) ("Tribute" or the "Company"), a specialty    pharmaceutical company with a primary focus on the acquisition, licensing,    development and promotion of healthcare products in

Copyright West LLC. Minimum 15 minutes delayed.